EPO Patents = 2

Forward Citations = 73

Loading Chart...

4 inventors (with patents filed for the assignee):

Charles Reay Mackay (6 out of 14 patents)

David Georges Zahra (3 out of 5 patents)

Peter Whitfeld (3 out of 3 patents)

4. Charles Reay Mackay (0 patent)

6 patents: Sort by Forward Citations

1. 8808701 - Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodies (2014-08-19),

2. 8361468 - Humanized anti-C5aR antibodies (2013-01-29),

3. 8337852 - Anti-C5aR antibodies with improved properties (2012-12-25),

4. 8268972 - Humanized anti-C5aR antibodies (2012-09-18),

5. 8084024 - Method for producing antibodies (2011-12-27),

6. 8071839 - Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use (2011-12-06),

G2 Inflammation Pty Ltd is a biotechnology company dedicated to developing innovative treatments for inflammatory diseases. Our focus is on harnessing the power of the immune system to target and combat inflammation. Through cutting-edge research and a commitment to patient care, we strive to improve the lives of those suffering from chronic inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#2 in Darlinghurst

#628 in Australia

Darlinghurst, Australia

G2 Inflammation Pty Ltd

Forward Citations = 73

4 inventors:

Charles Reay Mackay (6 out of 14 patents)

David Georges Zahra (3 out of 5 patents)

Peter Whitfeld (3 out of 3 patents)

4. Charles Reay Mackay (0 patent)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com